Clinical utility of neuroprotective agents in neurodegenerative diseases: Current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis
10.1517/13543784.2012.703178
Saved in:
Main Authors: | Dunkel, P., Chai, C.L., Sperlágh, B., Huleatt, P.B., Mátyus, P. |
---|---|
Other Authors: | PHARMACY |
Format: | Review |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/106630 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Micrornas and neurodegenerative diseases
by: Qiu L., et al.
Published: (2018) -
microRNAs and Neurodegenerative Diseases
by: Qiu L., et al.
Published: (2018) -
METABOLIC PROFILING OF MOTOR NEURONS DERIVED FROM PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
by: HOR JIN HUI
Published: (2020) -
Automated longitudinal monitoring of in vivo protein aggregation in neurodegenerative disease C. elegans models
by: Cornaglia, Matteo, et al.
Published: (2024) -
BCI-controlled smart wheelchair for amyotrophic lateral sclerosis patients
by: Espiritu, Noelle Marie D., et al.
Published: (2019)